Report #2888056

Received Mar 8, 2026

Office visit

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 52 yrs
State: NJ
Recovered: Not recovered
Vaccinated: Feb 28, 2026
Onset: Mar 4, 2026
Days to onset: 4
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	N/A	—	IM / RA

Symptoms (2)

Herpes zosterRash

Symptom narrative

Appropriately 4 days after receiving Capvaxive 0.5 Ml Syringe, subject/reporter experienced reactivation of HZ virus, presenting as Shingles. Early stage dermatomes detected across ribs, upper arm, and face (eye adjacent) on Thursday afternoon. By Friday, rash had begun to progress to mid-stage. Shingles confirmed by general practitioner & ophthalmologist; 1st dose valacyclovir course initiated Friday evening. Rash progression appears slow; however, progression noted.

Current illness

None

Medical history

Hashimoto?s hypothyroidism, obesity, asthma

Other medications

Tirzepitide, synthroid, levocertrizine, hydrochlorithiazide, progesterone, estrogen, ibuprofen

Allergies

Doxycycline, Advair